Biotech

All Articles

Galapagos stops CAR-T tissue therapy hearing over Parkinsonism scenario

.Galapagos has paused enrollment in a test of a BCMA-directed CAR-T cell therapy, pushing the brakes...

James Wilson leaving Penn to launch 2 new biotechs

.After more than 30 years, gene treatment pioneer James Wilson M.D., Ph.D., is leaving behind the Ed...

3 biotechs make an effort to beat the summer season heat energy by losing workers

.As biotechs attempt to switch a new page in August, at least 3 firms have shed personnel in tries t...

venBio elevates $528M for fifth lifestyle sciences VC fund

.Professional financial backing company venBio has lifted yet another half a billion dollars to acqu...

Otsuka pays $800M for Jnana as well as its own clinical-stage PKU medication

.Otsuka Drug has grabbed Boston-based Jnana Therapeutics for $800 thousand so the Oriental biotech c...

FibroGen gives up 75% of US team as asset flunks 2 more tests

.FibroGen is actually substantially reorganizing its own service, laying off 75% of its united state...

Tracon unwind full weeks after injectable PD-L1 inhibitor fall short

.Tracon Pharmaceuticals has actually decided to unwind procedures full weeks after an injectable imm...

Ideaya bags possibility on Biocytogen bispecific ADC in $400M bargain

.Ideaya Biosciences is betting $400 thousand in biobucks that a bispecific antibody-drug conjugate (...

Takeda takes $140M loss on failed epilepsy medication, proclaims FDA manage

.We already recognize that Takeda is actually intending to discover a course to the FDA for epilepsy...

VBI Vaccinations declare personal bankruptcy, finds possession sale

.Immunology biotech VBI Injections is actually diverting alarmingly near the point of no return, wit...